Rebamipide May Ease Dryness in Sjögren’s Patients via Immune Cell Regulation, Animal Study Suggests
News
Oral rebamipide, a gastroprotective medication approved in some countries, may slow the progression of Sjögren’s syndrome by increasing the number of regulatory B- and T-cells and reducing the production of ... Read more